| Authors: |
Wang S; Department of Hematology, Amsterdam UMC-Location Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC-Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Nijland M; University Medical Center Groningen, Groningen, The Netherlands., Strobbe L; Gelre Hospital, Zutphen, The Netherlands., Oosterveld M; Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Boersma R; Amphia Hospital, Breda, The Netherlands., Koene H; St Antonius Hospital, Utrecht, The Netherlands., Klerk C; Dijklander Hospital, Hoorn, The Netherlands., de Jongh E; Albert Schweitzer Hospital, Dordrecht, The Netherlands., Koster A; VieCuri Medical Center, Venlo, The Netherlands., Pruijt H; Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands., van der Poel M; Maastricht University Medical Center, Maastricht, The Netherlands., van Werkhoven E; Hemato-Oncology Foundation for Adults in The Netherlands (HOVON), Rotterdam, The Netherlands., Zanders H; Hemato-Oncology Foundation for Adults in The Netherlands (HOVON), Rotterdam, The Netherlands., Dinmohamed A; Netherlands Comprehensive Cancer Organization (IKNL), Enschede, The Netherlands., Pegtel M; Department of Pathology, Amsterdam UMC-Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Meek S; Foresight Diagnostics, Inc, Boulder, CO., Stowell SL; Foresight Diagnostics, Inc, Boulder, CO., Warinske H; Foresight Diagnostics, Inc, Boulder, CO., Alizadeh AA; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Kurtz DM; Foresight Diagnostics, Inc, Boulder, CO., Chamuleau MED; Department of Hematology, Amsterdam UMC-Location Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands. |
